Welcome to our dedicated page for LOVE HEMP GROUP PLC news (Ticker: WRHLF), a resource for investors and traders seeking the latest updates and insights on LOVE HEMP GROUP PLC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect LOVE HEMP GROUP PLC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of LOVE HEMP GROUP PLC's position in the market.
Love Hemp Group PLC (OTCQB: WRHLF) announced the failure of all resolutions at its recent General Meeting. Key proposals included the removal of Chairman Andrew Male, reduction of board salaries, and conducting a strategic review, with less than 5% votes in favor for each. The Chairman expressed gratitude to shareholders and emphasized the company’s commitment to growth and a potential up-listing to the London Stock Exchange. Love Hemp, a pioneer in the UK CBD market, offers more than 40 products across various platforms.
Love Hemp Group PLC (OTCQB: WRHLF) announced its inclusion in the Food Standard Agency's Public List of CBD products, marking a significant milestone in its regulatory journey. This acknowledgment allows Love Hemp to proceed to the validation stage, ensuring its products meet high-quality standards. The firm has invested over £300,000 in legal and scientific advice during a two-year compliance effort. The FSA's endorsement enhances consumer clarity and positions Love Hemp for growth across various sales channels, including e-commerce and retail.
Love Hemp Group PLC has released its unaudited interim results for the six months ending December 31, 2021. Revenue decreased to £1,736,817, down from £2,379,144 in the prior period, with gross margin dropping to 20% from 48%. The operating loss increased to £5,085,143 from £1,019,858. Despite these setbacks, the company launched a national media campaign featuring Anthony Joshua and is working towards cost savings through operational restructuring, including consolidation of facilities. The Board remains optimistic about future sales growth.
Love Hemp Group PLC (OTCQB: WRHLF) announced receipt of a requisition letter from Pershing Nominees Limited on February 11, 2022, seeking a general meeting to propose several resolutions. Key points include the removal of Chairman Andrew Male, a 75% salary reduction for directors, and a strategic review potentially leading to a sale or partnership. The board urges shareholders to vote against the resolutions, emphasizing recent fundraising success and ongoing efforts to achieve Main Market listing. A general meeting is scheduled for April 1, 2022.
Love Hemp Group (OTCQB:WRHLF) has achieved significant recognition at the Beauty Shortlist Awards held on March 2, 2022, winning four accolades including Best CBD Capsules for its 300mg product. Additionally, the company was honored as Leading CBD Brand of the Year - UK 2021 for the second consecutive year at the Commercial Cannabis Awards. Other award-winning products include CBD Oil Drops and CBD Infused Body Salve. These accolades highlight Love Hemp's commitment to quality within the CBD health and wellness sector.
Love Hemp Group (OTCQB:WRHLF) has announced that it currently has 1,198,804,631 ordinary shares outstanding, each entitling one vote. This figure will serve as the denominator for shareholders to determine if they need to notify changes in their interests according to the Financial Conduct Authority's rules. The company, which specializes in high-quality CBD products, has recently rebranded from World High Life to Love Hemp Group to align with its business focus. This announcement is regarded as inside information as per Market Abuse Regulation.
Love Hemp Group PLC (AQSE:LIFE)(OTCQB:WRHLF) announced a corporate update on February 22, 2022, highlighting key changes in its Board of Directors. Graham Mullis and Garry Cook have joined as Non-Executive Directors, while James Ward has resigned. The company completed its shares for debt program, converting £505,557 into 50,555,750 new ordinary shares at 1p each. This move, alongside a recent £2.0 million oversubscribed fundraising, aims to bolster the company's balance sheet. The new shares will start trading on the AQSE Growth Market on February 25, 2022.
Love Hemp Group PLC (OTCQB:WRHLF) has achieved a significant milestone by becoming the first CBD brand to have its products listed on eBay UK. This includes a variety of sprays, drops, and edibles available in the Health and Beauty category.
CEO Tony Calamita highlighted the development as crucial for expanding brand awareness, given eBay's impressive 1.7 billion monthly visits. This launch enhances Love Hemp's distribution network, which already includes major platforms like Amazon and Holland & Barrett.
Love Hemp Group PLC (OTCQB: WRHLF) has announced the expansion of its CBD product offerings via Deliveroo across six new locations in London and Manchester. Following a successful pilot with Deliveroo, the company aims to enhance brand visibility and customer access. CEO Tony Calamita emphasized that this expansion supports a 'just in time' purchasing model, reinforcing their commitment to health and wellness solutions. Love Hemp Group is a pioneer in the high-quality CBD market, offering over 40 products through various online platforms and retail locations.
Love Hemp Group PLC (OTCQB: WRHLF) has successfully completed a £2.0 million fundraising, announced on February 4, 2022, through the issuance of 206 million new ordinary shares at 1p each. The fundraising was oversubscribed and will be used for general working capital and business streamlining efforts. Following this transaction, the company will have 1,148,248,881 ordinary shares in issue. Admission of the new shares to the AQSE Growth Market is expected on February 14, 2022. Chairman Andrew Male emphasized the positive reception from investors and the company's growth trajectory in the CBD market.
FAQ